This information is intended for Canadian residents.
Sanofi is a leader in the global pharmaceutical market, with an extensive line of prescription medicines. Links to comprehensive information about our pharmaceutical products are listed below, most frequently in the form of a product monograph.This information has been approved by Health Canada and should be read and discussed in consultation with a health care professional.
Adlyxine™
Admelog™ and Admelog™ SoloSTAR®
(insulin lispro injection)
Aldurazyme®
AllStar™ Pro
Alprolix®
(coagulation factor IX (recombinant), Fc fusion protein)
Anandron®
(nilutamide)
Apidra®
Atrovent®
(ipratropium bromide)
Aubagio®
(teriflunomide)
Avalide®
(irbesartan, hydrochlorothiazide)
Avapro®
(irbesartan)
Buscopan®
Calcimar®
(calcitonin-salmon)
Caprelsa®
Cerdelga®
Cerezyme®
ClikSTAR®
Clolar®
(clofarabine for injection)
Clomid®
(clomiphene citrate)
Condyline®
(podofilox topical solution)
Cyclomen®
(danazol)
Demerol®
(meperidine hydrocholoride)
Diabeta®
(glyburide)
Dupixent®
(dupilumab)
Eligard®
(leuprolide acetate)
Eloctate®
(antihemophilic factor (recombinant BDD), Fc fusion protein )
Eloxatin®
(oxaliplatin)
Fabrazyme®
(agalsidase beta)
Fasturtec®
(rasburicase)
Ferrlecit®
(sodium ferric gluconate)
Flagyl®
(metronidazole)
Flagystatin®
(metronidazole, nystatin)
Fludara®
(fludarabine phosphate)
Glucophage®
Trademark of Merck Santé s.a.s. Commercialized in Canada by sanofi-aventis. (metformin hydrochloride)
Jevtana®
JuniorSTAR™
Kayexalate®
(sodium polystyrene sulfonate)
Kevzara®
Lantus®
(insuline glargine)
For more information, contact Sanofi Canada at 1-888-852-6887Lasix® Oral Solution
(furosemide)
Lasix® Special
(furosemide)
Lemtrada®
Libtayo™
(cemiplimab)
Lovenox® / Lovenox® HP
(enoxaparin sodium)
Mersyndol® with Codeine
(acetaminophen, codeine phosphate, doxylamine succinate)
Mozobil®
(plerixafor injection)
Multaq®
(dronedarone tablets)
- Product Monograph
- Suggested prescriber checklist
- Healthcare professional information sheet
- Safety information for the public - Aug. 4 2011 (permanent atrial fibrillation)
- Safety Information for healthcare professionals - July 29 2011 (permanent atrial fibrillation)
- Safety information for the public - March 15 2011 (liver injury)
- Safety information for healthcare professionals - March 10 2011 (hepatocellular liver injury)
- Information for health professionals (PALLAS study and pulmonary safety)
- Information for the public (PALLAS study)
Myochrysine®
(sodium aurothiomalate)
Myozyme®
(alglucosidase alfa)
Nalcrom®
(sodium cromoglycate)
Nasacort® AQ
(triamcinolone acetonide)
Nitrolingual® Pumpspray
Trademark of G. Pohl-Boskamp GmbH & Co. Commercialized in Canada by sanofi-aventis. (nitroglycerin)
Novahistex® DH
(hydrocodone bitartrate, phenylephrine hydrochloride)
Novahistine® DH
(hydrocodone bitartrate, phenylephrine hydrochloride)
Nozinan®
(methotrimeprazine)
Pediapred®
(prednisolone sodium phosphate)
Plaquenil®
(hydroxychloroquine sulfate)
Praluent™
(alirocumab)
Primaquine®
(primaquine phosphate)
Renagel®
(sevelamer hydrochloride tablets)
Renvela®
(sevelamer carbonate tablets)
Resonium® Calcium
(calcium polystyrene sulfonate)
Rifadin®
(rifampin)
Rilutek®
(riluzole)
Rythmodan®
(disopyramide)
Sectral®
(acebutolol hydrochloride)
Seprafilm®
(adhesion barrier)
Sofracort®
(framycetin sulphate, gramicidin, dexamethasone)
Soliqua™
(insulin glargine and lixisenatide for injection)
Suprefact®
(buserelin acetate)
Suprefact® Depot 2 months/3 months
(buserelin acetate implant)
Synvisc® /Synvisc-One®
Talwin®
(pentazocine hydrochloride)
Taxotere®
(docetaxel)
Thymoglobulin®
(anti-thymocyte globulin)
Thyrogen®
(thyrotropin alpha)
Toujeo™ SoloSTAR®
Tussionex® Suspension and Tablets
(hydrocodone resin complex, phenyltoloxamine resin complex)
Xatral®
(alfuzosin hydrochloride)
Zaroxolyn®
(metolazone)